Status epilepticus resident survival guide: Difference between revisions
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
Line 33: | Line 33: | ||
{{familytree/start |summary=Status epilepticus}} | {{familytree/start |summary=Status epilepticus}} | ||
{{familytree | | | | | | | | | | | | | | | | | A11 | | | | | | | | | | | | | | | | | | | | | |A11= | {{familytree | | | | | | | | | | | | | | | | | A11 | | | | | | | | | | | | | | | | | | | | | |A11=<div style="float: left; text-align: left; line-height: 150% ">'''Characterize the symptoms:'''<br>❑ Tonic phase with muscle spasms<br> ❑ Rapid jerky movement<br> ❑ Uprolling of eyes<br> ❑ Tongue biting<br> ❑ [[Incontinence]] | ||
---- | ---- | ||
'''Determine the onset of symptoms:''' | '''Determine the onset of symptoms:''' | ||
❑ Ask a witness</div>}} | ❑ Ask a witness</div>}} | ||
{{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | B01 | | | | | | | | | | | | | | | | | | | | | |B01='''General measures to be done SIMULTANEOUSLY and in PARALLEL to the administration of antiepileptic medications ( Emergency):'''<br | {{familytree | | | | | | | | | | | | | | | | | B01 | | | | | | | | | | | | | | | | | | | | | |B01=<div style="float: left; text-align: left; line-height: 150% ">'''General measures to be done SIMULTANEOUSLY and in PARALLEL to the administration of antiepileptic medications ( Emergency):'''<br> '''Begin initial care:''' <br>❑ Turn patient to side <br> ❑ Secure airway<br> ❑ Assess respiratory and cardiac functions <br> ❑ Administer high concentration O<sub>2</sub> <br> ❑ Maintain blood pressure <br> ❑ Establish IV access<br> ❑ Institute regular monitoring for [[pulse]], [[blood pressure]], [[temperature]]<br> ❑ [[ECG]] monitoring<br> ❑ Check fingerstick [[glucose]], and correct [[hypoglycemia]] if present '''( Emergency)''' | ||
---- | ---- | ||
'''Order labs:''' <br> ❑ [[CBC|Full blood count]] <br> ❑ [[Electrolytes|Plasma electrolytes]] <br> ❑ [[ABG|Blood gases]] <br> ❑ [[Glucose]] <br> ❑ Renal and [[LFT|liver function]]<br>❑ Serum [[calcium]] and [[magnesium]]<br> ❑ Blood clotting <br> ❑ Drug levels (if patient is on AED) <br> ❑ Obtain 5 ml of serum and 50 ml of urine sample for toxicology screen | '''Order labs:''' <br> ❑ [[CBC|Full blood count]] <br> ❑ [[Electrolytes|Plasma electrolytes]] <br> ❑ [[ABG|Blood gases]] <br> ❑ [[Glucose]] <br> ❑ Renal and [[LFT|liver function]]<br>❑ Serum [[calcium]] and [[magnesium]]<br> ❑ Blood clotting <br> ❑ Drug levels (if patient is on AED) <br> ❑ Obtain 5 ml of serum and 50 ml of urine sample for toxicology screen | ||
Line 51: | Line 51: | ||
</div>}} | </div>}} | ||
{{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | C01 | | | | | | | | | | | | | | | | | | | | | |C01= | {{familytree | | | | | | | | | | | | | | | | | C01 | | | | | | | | | | | | | | | | | | | | | |C01=<br> <div style="float: left; text-align: left; line-height: 150% ">'''Begin treatment ASAP ( Emergency):'''<br> | ||
'''Administer benzodiazepines:'''<br> | '''Administer benzodiazepines:'''<br> | ||
❑ IV [[lorazepam]] (0.1 mg/kg)<ref name="pmid21939901">{{cite journal| author=Rossetti AO, Lowenstein DH| title=Management of refractory status epilepticus in adults: still more questions than answers. | journal=Lancet Neurol | year= 2011 | volume= 10 | issue= 10 | pages= 922-30 | pmid=21939901 | doi=10.1016/S1474-4422(11)70187-9 | pmc=PMC3202016 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21939901 }} </ref> | ❑ IV [[lorazepam]] (0.1 mg/kg)<ref name="pmid21939901">{{cite journal| author=Rossetti AO, Lowenstein DH| title=Management of refractory status epilepticus in adults: still more questions than answers. | journal=Lancet Neurol | year= 2011 | volume= 10 | issue= 10 | pages= 922-30 | pmid=21939901 | doi=10.1016/S1474-4422(11)70187-9 | pmc=PMC3202016 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21939901 }} </ref> | ||
Line 59: | Line 59: | ||
❑ IV [[clonazepam]] (0.015 mg/kg)<ref name="pmid21939901">{{cite journal| author=Rossetti AO, Lowenstein DH| title=Management of refractory status epilepticus in adults: still more questions than answers. | journal=Lancet Neurol | year= 2011 | volume= 10 | issue= 10 | pages= 922-30 | pmid=21939901 | doi=10.1016/S1474-4422(11)70187-9 | pmc=PMC3202016 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21939901 }} </ref></div>}} | ❑ IV [[clonazepam]] (0.015 mg/kg)<ref name="pmid21939901">{{cite journal| author=Rossetti AO, Lowenstein DH| title=Management of refractory status epilepticus in adults: still more questions than answers. | journal=Lancet Neurol | year= 2011 | volume= 10 | issue= 10 | pages= 922-30 | pmid=21939901 | doi=10.1016/S1474-4422(11)70187-9 | pmc=PMC3202016 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21939901 }} </ref></div>}} | ||
{{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | G01 | | | | | | | | | | | | | | | | | | | | | |G01='''Recurrent or ongoing seizure ( 5-30 mins after onset)? ( Emergency)''' <br | {{familytree | | | | | | | | | | | | | | | | | G01 | | | | | | | | | | | | | | | | | | | | | |G01=<div style="float: left; text-align: left; line-height: 150% ">'''Recurrent or ongoing seizure ( 5-30 mins after onset)? ( Emergency)''' <br> | ||
'''Administer IV antiepileptic drugs:'''<br> | '''Administer IV antiepileptic drugs:'''<br> | ||
❑ IV [[phenytoin]] ( 20-30 mg/kg),<ref name="pmid21939901">{{cite journal| author=Rossetti AO, Lowenstein DH| title=Management of refractory status epilepticus in adults: still more questions than answers. | journal=Lancet Neurol | year= 2011 | volume= 10 | issue= 10 | pages= 922-30 | pmid=21939901 | doi=10.1016/S1474-4422(11)70187-9 | pmc=PMC3202016 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21939901 }} </ref> monitor ECG during the infusion<br> | ❑ IV [[phenytoin]] ( 20-30 mg/kg),<ref name="pmid21939901">{{cite journal| author=Rossetti AO, Lowenstein DH| title=Management of refractory status epilepticus in adults: still more questions than answers. | journal=Lancet Neurol | year= 2011 | volume= 10 | issue= 10 | pages= 922-30 | pmid=21939901 | doi=10.1016/S1474-4422(11)70187-9 | pmc=PMC3202016 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21939901 }} </ref> monitor ECG during the infusion<br> | ||
Line 68: | Line 68: | ||
OR <br> ❑ [[Levetiracetam]] (20-30 mg/kg)<ref name="pmid21939901">{{cite journal| author=Rossetti AO, Lowenstein DH| title=Management of refractory status epilepticus in adults: still more questions than answers. | journal=Lancet Neurol | year= 2011 | volume= 10 | issue= 10 | pages= 922-30 | pmid=21939901 | doi=10.1016/S1474-4422(11)70187-9 | pmc=PMC3202016 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21939901 }} </ref></div>}} | OR <br> ❑ [[Levetiracetam]] (20-30 mg/kg)<ref name="pmid21939901">{{cite journal| author=Rossetti AO, Lowenstein DH| title=Management of refractory status epilepticus in adults: still more questions than answers. | journal=Lancet Neurol | year= 2011 | volume= 10 | issue= 10 | pages= 922-30 | pmid=21939901 | doi=10.1016/S1474-4422(11)70187-9 | pmc=PMC3202016 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21939901 }} </ref></div>}} | ||
{{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | I01 | | | | | | | | | | | | | | | | | | | | | |I01= | {{familytree | | | | | | | | | | | | | | | | | I01 | | | | | | | | | | | | | | | | | | | | | |I01=<br><div style="float: left; text-align: left; line-height: 150% ">'''Recurrent or ongoing seizure ( >30 mins after onset)? ( Emergency)''' | ||
'''Elective coma induction with anesthestic agents:<ref name="pmid21939901">{{cite journal| author=Rossetti AO, Lowenstein DH| title=Management of refractory status epilepticus in adults: still more questions than answers. | journal=Lancet Neurol | year= 2011 | volume= 10 | issue= 10 | pages= 922-30 | pmid=21939901 | doi=10.1016/S1474-4422(11)70187-9 | pmc=PMC3202016 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21939901 }} </ref>'''<br> | '''Elective coma induction with anesthestic agents:<ref name="pmid21939901">{{cite journal| author=Rossetti AO, Lowenstein DH| title=Management of refractory status epilepticus in adults: still more questions than answers. | journal=Lancet Neurol | year= 2011 | volume= 10 | issue= 10 | pages= 922-30 | pmid=21939901 | doi=10.1016/S1474-4422(11)70187-9 | pmc=PMC3202016 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21939901 }} </ref>'''<br> | ||
❑ [[Midazolam]] (Loading dose: 0.2 mg/kg; maintenance dose: 0.2-0.6 mg/kg/hour)<br> | ❑ [[Midazolam]] (Loading dose: 0.2 mg/kg; maintenance dose: 0.2-0.6 mg/kg/hour)<br> | ||
Line 81: | Line 81: | ||
❑ Monitor complications: [[hyperthermia]], [[hypertension]], [[tachycardia]], [[arrhythmia]], [[hypoxia]], [[metabolic acidosis]], [[hyperkalemia]], [[hyperglycemia]], [[hypoglycemia]], [[cardiac failure|high output cardiac failure]], [[pulmonary edema]], [[pulmonary hypertension]]<ref name="pmid16488380">{{cite journal| author=Chen JW, Wasterlain CG| title=Status epilepticus: pathophysiology and management in adults. | journal=Lancet Neurol | year= 2006 | volume= 5 | issue= 3 | pages= 246-56 | pmid=16488380 | doi=10.1016/S1474-4422(06)70374-X | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16488380 }} </ref></div>}} | ❑ Monitor complications: [[hyperthermia]], [[hypertension]], [[tachycardia]], [[arrhythmia]], [[hypoxia]], [[metabolic acidosis]], [[hyperkalemia]], [[hyperglycemia]], [[hypoglycemia]], [[cardiac failure|high output cardiac failure]], [[pulmonary edema]], [[pulmonary hypertension]]<ref name="pmid16488380">{{cite journal| author=Chen JW, Wasterlain CG| title=Status epilepticus: pathophysiology and management in adults. | journal=Lancet Neurol | year= 2006 | volume= 5 | issue= 3 | pages= 246-56 | pmid=16488380 | doi=10.1016/S1474-4422(06)70374-X | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16488380 }} </ref></div>}} | ||
{{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | K01 | | | | | | | | | | | | | | | | | | | | | | K01= | {{familytree | | | | | | | | | | | | | | | | | K01 | | | | | | | | | | | | | | | | | | | | | | K01= <div style="float: left; text-align: left; line-height: 150% ">'''Recurrent or ongoing seizure ( >48 hours after onset)?'''<br> | ||
'''Consider changing the anesthetic agent to:'''<br> | '''Consider changing the anesthetic agent to:'''<br> | ||
❑ [[Thiopental]] (Loading dose: 1-2 mg/kg; maintenance dose: 1-5 mg/kg/hour)<br> | ❑ [[Thiopental]] (Loading dose: 1-2 mg/kg; maintenance dose: 1-5 mg/kg/hour)<br> |
Revision as of 14:27, 29 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Vidit Bhargava, M.B.B.S [2]; Rim Halaby, M.D. [3]
Definition
Status epilepticus is defined as continuous clinical and/or electroencephalographic seizure persisting longer than 5 minutes or the occurrence of two or more episodes of seizures within one hour without returning to the baseline level of consciousness between the seizures.[1]
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Status epilepticus is a life threatening condition by itself because it results in serious immediate and long term morbidity and mortality if the convulsive seize is not terminated by 30 minutes; therefore, treatment is required urgently.
Common Causes
- Alcoholism
- Brain abscess
- Brain trauma
- Cardiac arrest
- Cerebrovascular disorders
- CNS tumor
- Drug toxicity
- Electrolytes abnormalities
- Encephalitis
- Hypertensive encephalopathy
- Hypoglycemia
- Hypoxia
- Low antiepileptic drug levels in patients with epilepsy
- Meningitis
- Sepsis
- Stroke
- Uremia
- Withdrawal from opioids, benzodiazepine, barbiturates or alcohol[2][1]
Management
Shown below is an algorithm summarizing the approach to status epilepticus. The goal of the treatment is to stop the seizure as soon as possible; therefore, begin the general measures and administer the antiepileptic medications (AED) SIMULTANEOUSLY.
Characterize the symptoms: ❑ Tonic phase with muscle spasms ❑ Rapid jerky movement ❑ Uprolling of eyes ❑ Tongue biting ❑ Incontinence Determine the onset of symptoms: ❑ Ask a witness | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
General measures to be done SIMULTANEOUSLY and in PARALLEL to the administration of antiepileptic medications ( Emergency): Begin initial care: ❑ Turn patient to side ❑ Secure airway ❑ Assess respiratory and cardiac functions ❑ Administer high concentration O2 ❑ Maintain blood pressure ❑ Establish IV access ❑ Institute regular monitoring for pulse, blood pressure, temperature ❑ ECG monitoring ❑ Check fingerstick glucose, and correct hypoglycemia if present ( Emergency) Order labs: Consider vitamin deficiencies: Consider alternative diagnosis: Treat acidosis if severe | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recurrent or ongoing seizure ( 5-30 mins after onset)? ( Emergency) Administer IV antiepileptic drugs: ❑ Levetiracetam (20-30 mg/kg)[3] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recurrent or ongoing seizure ( >30 mins after onset)? ( Emergency)
Elective coma induction with anesthestic agents:[3] Ensure full intensive care support: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recurrent or ongoing seizure ( >48 hours after onset)? Consider changing the anesthetic agent to: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- Make sure to secure airway and maintain blood pressure within normal ranges, then administer anticonvulsants and then proceed to complete the diagnostic workup.[4]
- Consult neurology and anesthesiology.
- In the case of seizures lasting more than 5 minutes, it is beneficial do begin pre-hospital treatment with rectal diazepam (15-20 mg) among adults and children known to have frequent seizure episodes. IV lorazepam (2 mg, may repeat one) or IV diazepam (5 mg, may repeat once) can be started by well-trained teams of paramedics during the pre-hospital care of patients with seizures lasting more than 5 minutes.[4]
- The initial treatment with IV benzodiazepines ( lorazepam, midazolam or diazepam) may be repeated once 10 minutes following the first administered dose.
- Buccal midazolam (10 mg) or rectal diazepam (15-20 mg) can be used if IV access could not be established to administer IV benzodiazepine.
Dont's
- Don't delay the initiation of treatment during the initial diagnostic evaluation.[4]
References
- ↑ 1.0 1.1 Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T; et al. (2012). "Guidelines for the evaluation and management of status epilepticus". Neurocrit Care. 17 (1): 3–23. doi:10.1007/s12028-012-9695-z. PMID 22528274.
- ↑ Trinka E, Höfler J, Zerbs A (2012). "Causes of status epilepticus". Epilepsia. 53 Suppl 4: 127–38. doi:10.1111/j.1528-1167.2012.03622.x. PMID 22946730.
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 Rossetti AO, Lowenstein DH (2011). "Management of refractory status epilepticus in adults: still more questions than answers". Lancet Neurol. 10 (10): 922–30. doi:10.1016/S1474-4422(11)70187-9. PMC 3202016. PMID 21939901.
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 Chen JW, Wasterlain CG (2006). "Status epilepticus: pathophysiology and management in adults". Lancet Neurol. 5 (3): 246–56. doi:10.1016/S1474-4422(06)70374-X. PMID 16488380.
- ↑ Lowenstein DH, Alldredge BK (1998). "Status epilepticus". N Engl J Med. 338 (14): 970–6. doi:10.1056/NEJM199804023381407. PMID 9521986.